KOTRA | KOTRA INDUSTRIES BHD

6
4.28 (3.38%)

T-O (am): 0.000 (08:59:00)
Last updated: 16:35

Fundamental This feature is limited for iSaham clients only
Technical This feature is limited for iSaham clients only
Total Score This feature is limited for iSaham clients only

KOTRA | KOTRA INDUSTRIES BHD

KOTRA Fundamental Trend

FCON: This feature is limited for iSaham Pro only | Sharpe Ratio: This feature is limited for iSaham Pro only | LTS: This feature is limited for iSaham Pro only


Chart:

KOTRA Quarter Reports

Select columns required and click "Update" to save your preferences

KOTRA Historical Dividends

KOTRA Financial Ratios

EPS 26.98 sen
Trailing PE (Sector Median: 17.6) 15.8
PEG 2.31
Altman Z 2.3
Beaver 0.874
Current Ratio 2.9
Debt-Equity (DE) Ratio 0.2
FCF Yield 1.56 %
Revenue QoQ -17.01 %
Revenue YoY -5.41%
Profit QoQ 12.52 %
Profit YoY -5.67 %
Profit Margin (Sector Median: 6.3) 16.98 %
ROE (ROIC: 17.19) 17.19 %
Dividend Per Share (DPS) 25.5 sen
Dividend Yield (DY) 5.96 %

KOTRA Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 17.6)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 6.3)
ROE (ROIC: 16.24)
Altman Z

KOTRA Fair Value

Weighted Average Fair Value: This feature is limited for iSaham Pro only

Discounted Cash Flow (DCF) 5% Growth This feature is limited for iSaham Pro only
Discounted Cash Flow (DCF) 10% Growth This feature is limited for iSaham Pro only
Relative Valuation This feature is limited for iSaham Pro only
Graham Formula This feature is limited for iSaham Pro only
Graham Number This feature is limited for iSaham Pro only
Net Tangible Asset (NTA) 1.74
Consistent QR FV This feature is limited for iSaham Pro only
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] 10.96
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 56.97
Expected Revenue (M) 438.53
Expected Growth (%) 20.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

KOTRA Directors Share Purchases (Beta)


No transaction in the last 2 months.

KOTRA Summary


Market Cap: 634 M.

Market Cap Class: Middlers

Number of Shares: 148 M.

Adjusted Float: 56.4%.

Stock highly correlated with

DCHCARE (89%)

MENTIGA (88%)

PWROOT (88%)

TWRREIT (88%)

Kotra Industries Berhad, an investment holding company is engaged in developing, manufacturing and trading pharmaceutical and healthcare products in Malaysia and other countries in the Asia Pacific. Kotra Industries Berhad is a subsidiary of Piong Nam Kim Holdings Sdn. Bhd. It offers pharmaceutical products in various dosage forms, which include tablets, capsules, cream/ointment/gel, liquid, dry powder preparations and injectables. The company manufactures over-the-counter (OTC) products that include dietary supplements for infants and teenagers, multivitamin tablets and syrups for kids, vitamin and mineral supplements for pregnant and lactating women, antioxidant vitamins for adults, products for weight gain-related conditions, and wellness products for seniors. It also offers over-the-counter and prescription products, such as peripheral vasolidators, antacid and gastric ulcer remedies, antifungals, dermatologicals, anthelmentics, cough preparations, analgesics and antipyretics, mouth and throat preparations, and antirheumatics. The company's prescription products also include antihistamines/antiemetics, cold preparations, anti-asthmatics, anti-diarrhoeals, antibiotics, antivirals, corticosteroids, anaesthetics, vitamins and minerals, anti-inflammatory products, antispasmodics, antimalarials, anticoagulants and hormones and gynaecological products including Predicates ovulation test kits and Thames sperm enhancer kits. It offers OTC health supplements under Appeton brand, nutriceutical beverages under the Booster brand, anti-fungal Creobic Cream and a range of prescriptive products under Axcel and Vaxcel brand names. The company was incorporated in 1985 and is based in Melaka, Malaysia.

Sectors: Consumer Products, Healthcare, Pharmaceuticals

Code: 0002

Website: http://www.kotrapharma.com

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

KOTRA Top Shareholdings

Updated on 29-Sep-2023

Shareholder % Value (M)
Piong Nam Kim Holdings Sdn Bhd 43.57% 276.58
Piong Teck Onn 10.98% 69.71
Piong Teck Yen 3.92% 24.88
Piong Teck Min 3.38% 21.46
Piong Chee Wei 2.55% 16.19
Platinum Essence Sdn. Bhd. 1.89% 12.0
Kok Hon Seng 1.69% 10.73
Cheah Chang Han 1.65% 10.47
Madam Chin Swee Chang 1.56% 9.91
Chin Swee Chang 1.56% 9.9
Ji Yeh Ming 1.35% 8.57
Seah Tin Kim 1.24% 7.87
Medisch Specialist Centre Sdn Bhd 1.12% 7.11
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.